Peter Heerma, Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX), sold 2,250 shares at $31.41 ($71K) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Scheduled sale ($71k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.41 | 1,125 | $35K | 49.9% |
| 2 | $31.58 | 1,125 | $36K | 50.1% |
| Total | $31.50 avg | 2,250 | $71K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |